Pharmanutra S.p.A. (BIT:PHN)
50.20
-0.10 (-0.20%)
Apr 2, 2025, 4:40 PM CET
Pharmanutra Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 16.61 | 12.83 | 15.05 | 13.77 | 14.07 | Upgrade
|
Depreciation & Amortization | 3.34 | 2.42 | 1.15 | 1.01 | 0.93 | Upgrade
|
Other Amortization | 0.17 | - | - | - | - | Upgrade
|
Provision & Write-off of Bad Debts | 0.14 | 0.21 | 0.17 | 0.15 | 1.25 | Upgrade
|
Other Operating Activities | 1.19 | 1.41 | 0.81 | 1.26 | 0.36 | Upgrade
|
Change in Accounts Receivable | -2.98 | 2.22 | -5.15 | -1.77 | -1.28 | Upgrade
|
Change in Inventory | 1.22 | -2.91 | -2.4 | -0.97 | -0.04 | Upgrade
|
Change in Accounts Payable | 1.43 | -0.78 | 7.14 | 2.58 | -0.99 | Upgrade
|
Change in Income Taxes | 0.02 | 2.55 | -3.04 | 3.59 | -1.62 | Upgrade
|
Change in Other Net Operating Assets | -0.7 | -5.87 | 3.74 | 0.81 | -0.89 | Upgrade
|
Operating Cash Flow | 20.5 | 12.09 | 17.47 | 20.41 | 11.8 | Upgrade
|
Operating Cash Flow Growth | 69.56% | -30.77% | -14.44% | 73.02% | -1.54% | Upgrade
|
Capital Expenditures | -4.25 | -13.25 | -26.16 | -4.99 | -1.68 | Upgrade
|
Sale of Property, Plant & Equipment | 0.66 | 0.55 | 0.27 | 0.08 | 0.35 | Upgrade
|
Investment in Securities | - | - | 0.25 | - | - | Upgrade
|
Other Investing Activities | 1.38 | -2.01 | -1.08 | -0.64 | 0.73 | Upgrade
|
Investing Cash Flow | -2.21 | -14.7 | -26.72 | -5.54 | -0.6 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 0 | Upgrade
|
Long-Term Debt Issued | 0.62 | 10.99 | 15.41 | 5.41 | - | Upgrade
|
Total Debt Issued | 0.62 | 10.99 | 15.41 | 5.41 | 0 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -3.76 | Upgrade
|
Long-Term Debt Repaid | -6.11 | -0.7 | -4.04 | -0.72 | -0.98 | Upgrade
|
Total Debt Repaid | -6.11 | -0.7 | -4.04 | -0.72 | -4.74 | Upgrade
|
Net Debt Issued (Repaid) | -5.49 | 10.29 | 11.38 | 4.69 | -4.74 | Upgrade
|
Repurchase of Common Stock | -0.55 | -1.65 | -2.36 | - | -0.03 | Upgrade
|
Common Dividends Paid | -8.17 | -7.71 | -6.85 | -6.49 | -4.45 | Upgrade
|
Other Financing Activities | -7.38 | -1.44 | -0.27 | -0.12 | 0.73 | Upgrade
|
Financing Cash Flow | -21.59 | -0.52 | 1.89 | -1.92 | -8.5 | Upgrade
|
Net Cash Flow | -3.31 | -3.13 | -7.36 | 12.95 | 2.7 | Upgrade
|
Free Cash Flow | 16.25 | -1.16 | -8.69 | 15.43 | 10.12 | Upgrade
|
Free Cash Flow Growth | - | - | - | 52.49% | 42.08% | Upgrade
|
Free Cash Flow Margin | 13.99% | -1.15% | -10.46% | 22.64% | 17.82% | Upgrade
|
Free Cash Flow Per Share | 1.69 | -0.12 | -0.90 | 1.59 | 1.04 | Upgrade
|
Levered Free Cash Flow | 12.86 | 2.25 | -14.67 | 11.35 | 5.51 | Upgrade
|
Unlevered Free Cash Flow | 13.53 | 2.75 | -14.63 | 11.36 | 5.53 | Upgrade
|
Change in Net Working Capital | 2.83 | 0.81 | 4.04 | -3.91 | 2.57 | Upgrade
|
Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.